S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.41 (+0.72%)
BABA   85.91 (-1.50%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.43 (-1.19%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.20%)
GE   109.93 (-1.60%)
DIS   80.05 (-1.19%)
AMC   7.91 (-2.83%)
PFE   32.40 (-1.76%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.41 (+0.72%)
BABA   85.91 (-1.50%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.43 (-1.19%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.20%)
GE   109.93 (-1.60%)
DIS   80.05 (-1.19%)
AMC   7.91 (-2.83%)
PFE   32.40 (-1.76%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.41 (+0.72%)
BABA   85.91 (-1.50%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.43 (-1.19%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.20%)
GE   109.93 (-1.60%)
DIS   80.05 (-1.19%)
AMC   7.91 (-2.83%)
PFE   32.40 (-1.76%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.41 (+0.72%)
BABA   85.91 (-1.50%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.43 (-1.19%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.20%)
GE   109.93 (-1.60%)
DIS   80.05 (-1.19%)
AMC   7.91 (-2.83%)
PFE   32.40 (-1.76%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
NASDAQ:CPRX

Catalyst Pharmaceuticals (CPRX) News Today

$12.14
+0.01 (+0.08%)
(As of 05:19 PM ET)
Compare
Today's Range
$12.11
▼
$12.60
50-Day Range
$12.10
▼
$15.02
52-Week Range
$11.09
▼
$22.11
Volume
788,476 shs
Average Volume
1.87 million shs
Market Capitalization
$1.29 billion
P/E Ratio
12.02
Dividend Yield
N/A
Price Target
$24.75
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability
SourceHeadline
MarketBeat logoCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) to Post FY2024 Earnings of $1.33 Per Share, Zacks Research Forecasts
americanbankingnews.com - September 25 at 1:58 AM
marketwatch.com logoCatalyst Pharmaceuticals Inc. stock falls Thursday, still outperforms market
marketwatch.com - September 21 at 7:43 PM
marketbeat.com logoLevel Four Advisory Services LLC Purchases New Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
marketbeat.com - September 20 at 4:18 AM
marketbeat.com logoBTC Capital Management Inc. Takes $275,000 Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
marketbeat.com - September 19 at 7:13 AM
finance.yahoo.com logoCatalyst Pharmaceuticals to Participate at the 2023 Cantor Global Healthcare Conference
finance.yahoo.com - September 18 at 8:44 AM
seekingalpha.com logoCatalyst Pharmaceuticals launches $500M mixed shelf offering - filing
seekingalpha.com - September 9 at 8:40 PM
finance.yahoo.com logoWhy Is Catalyst (CPRX) Down 14% Since Last Earnings Report?
finance.yahoo.com - September 8 at 3:40 PM
stocknews.com logoSeptember Buy, Sell or Hold for This Pharma Sock: Catalyst Pharmaceuticals (CPRX)
stocknews.com - September 8 at 2:11 PM
finance.yahoo.com logoUnraveling the Future of Catalyst Pharmaceuticals Inc (CPRX): A Deep Dive into Key Metrics
finance.yahoo.com - September 6 at 1:55 PM
marketbeat.com logo19,700 Shares in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Bought by Boulder Hill Capital Management LP
marketbeat.com - September 4 at 12:51 PM
marketbeat.com logoSwiss National Bank Trims Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
marketbeat.com - September 3 at 4:35 AM
marketbeat.com logoCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Bought by Citigroup Inc.
marketbeat.com - September 1 at 5:33 AM
seekingalpha.com logoCatalyst Pharmaceuticals: The Journey From Earnings Euphoria To Patent Perils
seekingalpha.com - August 30 at 5:36 PM
stocknews.com logo3 Pharma Stocks to Watch for Value in September
stocknews.com - August 29 at 3:21 PM
marketbeat.com logoPrincipal Financial Group Inc. Sells 18,527 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
marketbeat.com - August 29 at 4:49 AM
marketbeat.com logoZacks Research Brokers Cut Earnings Estimates for Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
marketbeat.com - August 25 at 5:54 AM
marketbeat.com logoTower Research Capital LLC TRC Acquires 15,442 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
marketbeat.com - August 25 at 4:52 AM
stocknews.com logo3 Value Pharma Stocks to Keep Watching
stocknews.com - August 24 at 6:05 PM
msn.com logoCantor Fitzgerald Reiterates Catalyst Pharmaceuticals (CPRX) Overweight Recommendation
msn.com - August 23 at 2:07 AM
stocknews.com logoCatalyst Pharmaceuticals (CPRX): Is Now the Time to Buy This Pharma Stock?
stocknews.com - August 21 at 2:05 PM
marketbeat.com logoCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Acquired by Russell Investments Group Ltd.
marketbeat.com - August 21 at 4:51 AM
marketbeat.com logoCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Acquired by Mirae Asset Global Investments Co. Ltd.
marketbeat.com - August 18 at 4:24 AM
finance.yahoo.com logoCatalyst Pharmaceuticals Announces Abstract on Lambert Eaton Myasthenic Syndrome (LEMS) to be Presented at the Upcoming IASLC 2023 World Conference of Lung Cancer
finance.yahoo.com - August 16 at 4:33 PM
finance.yahoo.com logoCatalyst Pharmaceuticals Announces Multiple Abstracts on FYCOMPA® (Perampanel) from Eisai Co, Ltd., to be Presented at the 35th International Epilepsy Congress
finance.yahoo.com - August 14 at 6:25 PM
marketbeat.com logoCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Sold by Barclays PLC
marketbeat.com - August 14 at 4:52 AM
msn.com logoCantor Fitzgerald Maintains Catalyst Pharmaceuticals (CPRX) Overweight Recommendation
msn.com - August 12 at 1:48 AM
marketbeat.com logoCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Given Consensus Recommendation of "Moderate Buy" by Analysts
marketbeat.com - August 11 at 4:43 PM
markets.businessinsider.com logo5 Analysts Have This to Say About Catalyst Pharmaceuticals
markets.businessinsider.com - August 11 at 3:47 PM
marketbeat.com logoCatalyst Pharmaceuticals (NASDAQ:CPRX) Rating Reiterated by HC Wainwright
marketbeat.com - August 11 at 8:27 AM
marketbeat.com logoCatalyst Pharmaceuticals (NASDAQ:CPRX) Given New $27.00 Price Target at Cantor Fitzgerald
marketbeat.com - August 11 at 8:14 AM
markets.businessinsider.com logoH.C. Wainwright Keeps Their Buy Rating on Catalyst Pharma (CPRX)
markets.businessinsider.com - August 11 at 6:59 AM
finance.yahoo.com logoCatalyst Pharmaceuticals Second Quarter 2023 Earnings: EPS: US$0.35 (vs US$0.21 in 2Q 2022)
finance.yahoo.com - August 11 at 6:59 AM
finanznachrichten.de logoCatalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Reports Strong Second Quarter 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - August 10 at 8:41 AM
finance.yahoo.com logoCatalyst Pharmaceuticals Reports Strong Second Quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - August 9 at 8:11 PM
marketbeat.com logoCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Sold by Los Angeles Capital Management LLC
marketbeat.com - August 4 at 5:51 AM
stocknews.com logoWhich is the Better Value Stock for August: Catalyst Pharmaceuticals, Inc. (CPRX) vs. Teva Pharmaceutical Industries (TEVA)?
stocknews.com - August 3 at 2:44 PM
marketbeat.com logoArtemis Investment Management LLP Grows Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
marketbeat.com - August 3 at 11:50 AM
marketbeat.com logoTexas Permanent School Fund Corp Has $1.36 Million Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
marketbeat.com - August 1 at 7:17 AM
marketbeat.com logoCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Short Interest Down 9.1% in July
marketbeat.com - July 31 at 4:52 AM
marketbeat.com logoGables Capital Management Inc. Sells 13,525 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
marketbeat.com - July 29 at 12:59 AM
marketbeat.com logoFY2023 EPS Estimates for Catalyst Pharmaceuticals, Inc. Raised by Cantor Fitzgerald (NASDAQ:CPRX)
marketbeat.com - July 28 at 7:35 AM
bizjournals.com logoPharmaceutical CEO to retire from public company he co-founded
bizjournals.com - July 27 at 3:55 AM
finanznachrichten.de logoCatalyst Pharmaceuticals, Inc.: Patrick J. McEnany Announces Intention to Retire as CEO of Catalyst Pharmaceuticals by Year-End
finanznachrichten.de - July 25 at 4:05 PM
marketwatch.com logoCatalyst Pharmaceuticals: Patrick McEnany to Retire as CEO by Year-End >CPRX
marketwatch.com - July 25 at 11:01 AM
finance.yahoo.com logoPatrick J. McEnany Announces Intention to Retire as CEO of Catalyst Pharmaceuticals by Year-End
finance.yahoo.com - July 25 at 11:01 AM
finance.yahoo.com logoCatalyst Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 9, 2023
finance.yahoo.com - July 24 at 8:11 AM
marketbeat.com logoQ2 2023 EPS Estimates for Catalyst Pharmaceuticals, Inc. Cut by Analyst (NASDAQ:CPRX)
marketbeat.com - July 24 at 1:33 AM
marketbeat.com logoRaymond James & Associates Has $923,000 Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
marketbeat.com - July 23 at 4:12 AM
markets.businessinsider.com logoWhere Catalyst Pharmaceuticals Stands With Analysts
markets.businessinsider.com - July 21 at 2:50 PM
finance.yahoo.com logoSanthera Announces Closing of Exclusive North America License Agreement with Catalyst Pharmaceuticals for Vamorolone
finance.yahoo.com - July 19 at 7:20 AM
Get Catalyst Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CPRX and its competitors with MarketBeat's FREE daily newsletter.



CPRX Media Mentions By Week

CPRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CPRX
News Sentiment
▼
0.71

0.49
▲
Average
Medical
News Sentiment

CPRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CPRX Articles
This Week
▼
6

5
▲
CPRX Articles
Average Week

Get Catalyst Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CPRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:CPRX) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -